A Clinical Trial to Assess the Efficacy and Safety of JMT103 in Patients With Refractory HCM
Clinical trial NCT04198480 · UNKNOWN
Trial details
- NCT number
- NCT04198480
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-24
- Primary completion
- 2021-07-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.